Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon-Alpha and Retinoic Acid with Radiation in Advanced Cervical Cancer
NCT01276730Phase 2Completed
- Sponsor
- University of Louisville
- Start
- Oct 2007
- Primary completion
- Aug 2015
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Interferon alfa-2b vaginal effervescent tablet, isotretinoin in Cervical Cancer (CC), sponsored by University of Louisville. Started Oct 2007; status: completed.
02
Drugs
Interferon alfa-2b vaginal effervescent tabletisotretinoin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT01276730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01276730.